Paper32407884
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.
Chorin E and 17 others. Heart Rhythm, 2020. Cited by 194 papers, by iCite.
Cite this record
ConductScience Library. QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin. Papers, record 32407884. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32407884
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azithromycin | Major topic |
| Betacoronavirus | Major topic |
| Coronavirus Infections | Major topic |
| Hydroxychloroquine | Major topic |
| Long QT Syndrome | Major topic |
| Pneumonia, Viral | Major topic |
| Torsades de Pointes | Major topic |
| Aged | |
| Anti-Bacterial Agents | |
| Antimalarials | |
| COVID-19 | |
| Female | |
| Humans | |
| Incidence | |
| Male | |
| Middle Aged | |
| Pandemics | |
| Retrospective Studies | |
| SARS-CoV-2 | |
| COVID-19 Drug Treatment |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17719337 | Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide. | Am J Cardiol | 2007 | https://conductscience.org/library/papers/17719337 | PubMed |
| 2 | 12861106 | Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. | Medicine (Baltimore) | 2003 | https://conductscience.org/library/papers/12861106 | PubMed |
| 3 | 16968849 | Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. | JAMA | 2006 | https://conductscience.org/library/papers/16968849 | PubMed |
| 4 | 32380291 | Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019. | Heart Rhythm | 2020 | https://conductscience.org/library/papers/32380291 | PubMed |
| 5 | 23872551 | Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus. | J Clin Rheumatol | 2013 | https://conductscience.org/library/papers/23872551 | PubMed |
| 6 | 25165550 | Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports. | Ther Adv Infect Dis | 2013 | https://conductscience.org/library/papers/25165550 | PubMed |
| 7 | 18427136 | Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. | Circulation | 2008 | https://conductscience.org/library/papers/18427136 | PubMed |
| 8 | 32247013 | Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. | Heart Rhythm | 2020 | https://conductscience.org/library/papers/32247013 | PubMed |
| 9 | 17239714 | Long QT syndrome in adults. | J Am Coll Cardiol | 2007 | https://conductscience.org/library/papers/17239714 | PubMed |
| 10 | 16762774 | Torsades de pointes induced by antibiotics. | Eur J Intern Med | 2006 | https://conductscience.org/library/papers/16762774 | PubMed |
| 11 | 20142454 | Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. | Circulation | 2010 | https://conductscience.org/library/papers/20142454 | PubMed |
| 12 | 32380288 | Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans. | Heart Rhythm | 2020 | https://conductscience.org/library/papers/32380288 | PubMed |
| 13 | 32488217 | The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin. | Nat Med | 2020 | https://conductscience.org/library/papers/32488217 | PubMed |
| 14 | 32205204 | RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. | Int J Antimicrob Agents | 2020 | https://conductscience.org/library/papers/32205204 | PubMed |
| 15 | 32020029 | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. | Cell Res | 2020 | https://conductscience.org/library/papers/32020029 | PubMed |
| 16 | 16920145 | An algorithm for continuous real-time QT interval monitoring. | J Electrocardiol | 2006 | https://conductscience.org/library/papers/16920145 | PubMed |
| 17 | 32359771 | Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19). | Mayo Clin Proc | 2020 | https://conductscience.org/library/papers/32359771 | PubMed |
| 18 | 32150618 | In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/32150618 | PubMed |
| 19 | 16615675 | Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. | Clin Toxicol (Phila) | 2006 | https://conductscience.org/library/papers/16615675 | PubMed |
| 20 | 32244059 | SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. | Heart Rhythm | 2020 | https://conductscience.org/library/papers/32244059 | PubMed |
Cited by164
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 194 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42067143 | QT interval prolongation and its related factors before and after receiving lopinavir-ritonavir in the COVID-19 era: a historical cohort study. | Virus Res | 2026 | https://conductscience.org/library/papers/42067143 | PubMed |
| 40479341 | The effect of coronavirus infection on QT and QTc intervals of hospitalized patients in Qazvin, Iran. | Ann Data Sci | 2022 | https://conductscience.org/library/papers/40479341 | PubMed |
| 39702045 | Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients. | BMC Cardiovasc Disord | 2024 | https://conductscience.org/library/papers/39702045 | PubMed |
| 38954228 | Prevalence, Outcomes, and Predictors of Prolonged Corrected QT Interval in Hydroxychloroquine-Naïve Hospitalized COVID-19 Patients. | Cardiovasc Toxicol | 2024 | https://conductscience.org/library/papers/38954228 | PubMed |
| 37530946 | COVID-19 Vaccination and Cardiac Arrhythmias: A Review. | Curr Cardiol Rep | 2023 | https://conductscience.org/library/papers/37530946 | PubMed |
| 37492089 | Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37492089 | PubMed |
| 37377231 | Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital. | Rev Peru Med Exp Salud Publica | 2023 | https://conductscience.org/library/papers/37377231 | PubMed |
| 37065296 | Characteristics of Cardiac Abnormalities in Pediatric Patients With Acute COVID-19. | Cureus | 2023 | https://conductscience.org/library/papers/37065296 | PubMed |
| 37059487 | Potential treatments of COVID-19: Drug repurposing and therapeutic interventions. | J Pharmacol Sci | 2023 | https://conductscience.org/library/papers/37059487 | PubMed |
| 36891179 | Pharmacy Challenges in Cardiac Patient Care During the COVID-19 Pandemic: Lessons Learnt For the Future. | Card Fail Rev | 2023 | https://conductscience.org/library/papers/36891179 | PubMed |
| 36888581 | SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. | PLoS One | 2023 | https://conductscience.org/library/papers/36888581 | PubMed |
| 36733512 | Practices, knowledge, and attitudes of community pharmacists towards dispensing drugs during the COVID-19 pandemic: A cross sectional study from Jordan. | Pharm Pract (Granada) | 2022 | https://conductscience.org/library/papers/36733512 | PubMed |
| 36732468 | Effects of hydroxychloroquine on atrial electrophysiology in in silico wild-type and PITX2+/- atrial cardiomyocytes. | Herz | 2023 | https://conductscience.org/library/papers/36732468 | PubMed |
| 36703736 | The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36703736 | PubMed |
| 36685029 | Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns. | J Res Med Sci | 2022 | https://conductscience.org/library/papers/36685029 | PubMed |
| 36644408 | Electrochemical sensor based on a ZnO-doped graphitized carbon for the electrocatalytic detection of the antibiotic hydroxychloroquine. Application: tap water and human urine. | J Appl Electrochem | 2023 | https://conductscience.org/library/papers/36644408 | PubMed |
| 36135437 | Effects of COVID-19 on Arrhythmia. | J Cardiovasc Dev Dis | 2022 | https://conductscience.org/library/papers/36135437 | PubMed |
| 36079177 | Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome. | J Clin Med | 2022 | https://conductscience.org/library/papers/36079177 | PubMed |
| 35892438 | Early Alterations of QTc in Patients with COVID-19 Treated with Hydroxychloroquine or Chloroquine in Libreville, Gabon. | Clin Pract | 2022 | https://conductscience.org/library/papers/35892438 | PubMed |
| 35885517 | Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35885517 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32407884
GET https://conductscience.org/api/papers/v1/32407884/references?page=2